Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia ...Middle East

- News
Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

Hence then, the article about study ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News